Austin Charette
CIK: 0002105444
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Charette Austin
Charette Austin (SEC CIK 0002105444) files insider reports with the SEC as Principal Accounting Officer of AGENUS INC (AGEN) and Principal Accounting Officer of MiNK Therapeutics, Inc. (INKT).
Signal8 holds 3 ownership filings by Charette Austin (2 Form 3, 1 Form 4), filed between Jan 16, 2026 and Apr 28, 2026. Those filings report 2 transactions, the latest on Apr 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Charette Austin's filings is in LEXINGTON, MA.
Recent filings by Charette Austin
- Apr 24, 2026: Grants or awards of AGEN derivative securities (2 lines, Form 4, code A).
Other insiders filing for AGENUS INC (AGEN)
- Wright Timothy, Director
- HARRISON THOMAS L, Director
- Marcucci Marco Tullio, Director
- ARMEN GARO H
- Corvese Brian, Director
- O'Day Steven J, Chief Medical Officer